Early Versus Delayed Bathing of Orthopaedic Surgical Wounds
NCT ID: NCT06014411
Last Updated: 2025-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
56 participants
INTERVENTIONAL
2024-01-29
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Those who do not wish to participate in the randomized trial will be invited to participate observationally (no randomization) and have the same prospective follow-up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urinary Infection and Colonization in Bone Procedures
NCT06896643
Effectiveness of the Delirium Zero Protocol to Prevent the Onset of Delirium in Patients Undergoing Hip Fracture Surgery
NCT07202208
Factors Affecting Surgical Recovery in Hospital Patients
NCT06502600
Improvement of Intraoperative Behavior of Staff to Prevent Postoperative Complications
NCT03158181
Risk Factors for Postoperative Complications in Major Non-cardiac Surgery: Post-hoc Analysis of the OPHIQUE Multicentre Study
NCT05824260
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will have follow-up with data collection at two, six and 12 weeks post-operatively. The primary outcome measure will be patient satisfaction as measured by a Likert Scale. The Likert Scale as utilized will be a patient reported outcome measure consisting of one question allowing the subject to express their attitude towards a particular subject: "How satisfied are you with your surgical treatment" with possible answers consisting of: "very satisfied", "somewhat satisfied", "neutral", "somewhat unsatisfied", and "very unsatisfied". The secondary outcome measures will be development of an infection (subcategorized as either superficial or deep) and development of peri-incisional inflammation (eg. adhesive rash).
Primary Objective: The primary objective of the study is to compare patient satisfaction as measured using a Likert Scale associated with early and delayed surgical site bathing.
Secondary Objectives: The secondary objective is to compare the infection rate of orthopaedic surgical wounds between early and delayed bathing.
Those who do not wish to participate in the randomized trial will be invited to participate observationally (no randomization) and have the same prospective follow-up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Delayed Bathing
Delayed bathing-- patients will be told to begin showering after wound exam and suture removal (10-20 day postoperative).
Time to bathing (delayed)
Delayed bathing-- patients will be told to begin showering after wound exam and suture removal (10-20 day postoperative).
Early Bathing
Early bathing--Patients will be told to remove dressings and begin showering with body soap on postoperative day 3.
Time to bathing (early)
Early bathing--Patients will be told to remove dressings and begin showering with body soap on postoperative day 3.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Time to bathing (delayed)
Delayed bathing-- patients will be told to begin showering after wound exam and suture removal (10-20 day postoperative).
Time to bathing (early)
Early bathing--Patients will be told to remove dressings and begin showering with body soap on postoperative day 3.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient who are not pregnant
* Isolated acute fractures of the upper or lower extremities (humerus, radius, ulna, femur, tibia, or fibula)
* Diagnosis of a fracture meeting indication for operative intervention
* Any fracture not requiring a splint for post-operative management
* Non-complicated wounds (non-traumatic wounds, closed injuries, fractures not requiring external fixation, and acute fracture surgery)
Exclusion Criteria
* Patients with multiple fractures
* Fractures in patients with underlying associated immune compromise
* Fractures in patients with underlying peripheral vascular disease
* Use of VAC
* Surgery performed through previous surgical wound
* Patient homeless
* Fractures in patients with underlying diabetes mellitus
* Complicated wounds (traumatic wounds, need for post-op wound care, open injuries, need for external fixation)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York Presbyterian Hospital
OTHER
Hospital for Special Surgery, New York
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
William Ricci
Chief Orthopaedic Trauma Service
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William M Ricci, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital for Special Surgery, New York
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NewYork-Presbyterian/Weill Cornell Medical Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-04023565
Identifier Type: OTHER
Identifier Source: secondary_id
2023-1723
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.